Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells

Cancer Immunol Res. 2015 Apr;3(4):356-67. doi: 10.1158/2326-6066.CIR-14-0186. Epub 2015 Jan 19.

Abstract

This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-κB, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD28 Antigens / metabolism
  • CD3 Complex / metabolism
  • Cell Proliferation
  • Chemokines / metabolism
  • Cytokine-Induced Killer Cells / immunology
  • Cytokines / metabolism
  • Female
  • Genetic Vectors
  • Humans
  • Immunophenotyping
  • Immunotherapy, Adoptive / methods*
  • Interleukin-2 / metabolism
  • Lentivirus / genetics
  • Lymphocyte Activation / immunology
  • Mice, Inbred NOD
  • Mice, SCID
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / therapy
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / immunology*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / immunology
  • Signal Transduction / immunology
  • T-Lymphocytes / immunology*
  • Xenograft Model Antitumor Assays

Substances

  • CD28 Antigens
  • CD3 Complex
  • CD3 antigen, zeta chain
  • Chemokines
  • Cytokines
  • Interleukin-2
  • Receptors, Antigen, T-Cell
  • Recombinant Fusion Proteins